Key Points
- One February conference featured focused ultrasound presentations.
- The Society of Interventional Oncology met February 4–8 in Savannah, Georgia, for its 2026 Annual Scientific Meeting.
Society of Interventional Oncology (SIO) Annual Scientific Meeting
SIO 2026 was held February 4–8 in Savannah, Georgia. With approximately 1,000 attendees, this conference features expert-led sessions, discussion of innovative practices, and opportunities to network with IO professionals. IO is considered as the fourth pillar of cancer therapy alongside medical, surgical, and radiation oncology.
“The field of interventional oncology is always progressing and advancing, and this was evident at the conference,” said Suzanne LeBlang, MD, the Foundation’s director of clinical relationships, who attended SIO 2026. “IO physicians have traditionally been fast to embrace new technologies to help care for patients.”
HistoSonics sponsored one of the meeting’s Industry Breakfast Symposiums, and it was titled “Histotripsy in Practice: Real-World Experience, Evidence, and Future Frontiers.”
The following presentations may also be of interest to the focused ultrasound community:
Genitourinary Session (5)
- Prostate Cancer: Treatment Decision Making presented by Timothy McClure, MD, MS
- Anatomic Considerations in Focal Treatment presented by Guilherme Mariotti, MD, MSc, PhD, MBA
- Focal Treatment in Prostate: The Best Way to Do It presented by David Woodrum, MD, PhD
- Renal Cancer Ablation: What is the Current Place of Ablation and Have We Agreed a Standardized Procedure? presented by Christos Georgiades, MD, PhD
- Roundtable Discussion: Challenging Cases, facilitated by Alex King, MBBS, FRCR and Christian Overduin, PhD
Emerging Non-Thermal Ablation Clinical Applications Session (2)
- Limitations of Thermal Ablation by Erica Knavel Koepsel, MD
- Current Status, Data, and Limitations of Histotripsy by Mishal Mendiratta-Lala, MD
Poster Reception (7)
- 305 – Adjunctive Techniques to Optimize Percutaneous Ablation of RCC: A Comprehensive Pictorial Overview
- 331 – Safety and Efficacy of Histotripsy Treatments Near Implanted Fudicials and Endovascular Coils in an In vivo Swine Model
- 414 – Radiomic Signal Changes Following Histotripsy Ablation of Metastatic Hepatic Lesions
- 478 – MRI-Guided Transurethral Ultrasound Ablation (TULSA) for Intermediate-Risk Prostate Cancer: Technology and Perioperative Outcomes of Randomized Trial vs. Robotic Prostatectomy
- 492 – Pioneering Pulse: The First Use of Endoscopic Histotripsy for Cancer Ablation and Immune Activation
- 500 – Retrospective Review of Complications Following Hepatic Histotripsy in Patients Receiving Uninterrupted Anticoagulation, Antiplatelet, and Targeted Systemic Therapy
- 542 – Site-Specific Antibody-Conjugated Microbubbles for Molecular Ultrasound Imaging of Hepatocellular Carcinoma (Not for focused ultrasound but interesting that they are creating new microbubbles.)
Liver Tumors (1)
- Ablation Techniques for Primary & Secondary Liver Tumors: A Comparative Review by R. Shalash, N. Baah, S. Contractor, C. Centner
All of the abstracts from this meeting have now been published in the Journal of Vascular and Interventional Radiology. Search the journal for all content listed above as well as your own key words or areas of interest.
Next year SIO 2027 will be held February 24–28, 2027, in Toronto, Ontario, Canada.